Kamyar Kalantar-Zadeh M.D. to Receptors, Calcitriol
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Receptors, Calcitriol.
Connection Strength
1.218
-
Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease. Clin J Am Soc Nephrol. 2009 Sep; 4(9):1529-39.
Score: 0.320
-
Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2008 Nov; 3(6):1769-76.
Score: 0.299
-
Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int. 2008 Jun; 73(12):1355-63.
Score: 0.289
-
Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients. J Ren Nutr. 2016 07; 26(4):265-9.
Score: 0.127
-
Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis. Pharmacoepidemiol Drug Saf. 2012 Nov; 21(11):1232-9.
Score: 0.099
-
Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl. 2010 Aug; (117):S10-21.
Score: 0.086